Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...

Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare infrastructure, advancements in medical research, and a growing elderly ...